Andrew J. Stewart - 24 Apr 2024 Form 4 Insider Report for Bausch & Lomb Corp (BLCO)

Role
Officer
Signature
/s/ Debra E. Levin, attorney-in-fact
Issuer symbol
BLCO
Transactions as of
24 Apr 2024
Net transactions value
-$58,751
Form type
4
Filing time
26 Apr 2024, 16:10:04 UTC
Previous filing
01 Mar 2024
Next filing
26 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLCO Common Shares, No Par Value Tax liability $58,751 -3,943 -7.9% $14.90 45,985 24 Apr 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Remarks:

The Reporting Person's title as an officer of the Issuer is President, Global Pharmaceuticals and International Consumer.